Neck Pain Treatment Solutions Market Outlook, Trends And Future Opportunities (2024-2031)

Neck Pain Treatment Solutions Market Outlook, Trends And Future Opportunities (2024-2031)

Neck Pain Treatment Solutions Market, By Product Type (Cervical Collars, Traction Devices, Epidural Steroid Injections, NSAIDs, Opioids, Muscle Relaxants, Others (Physical Therapy, Acupuncture etc.)), By Application (Degenerative Disc Disease, Herniated Discs, Trauma and Fractures, Osteoarthritis, Whiplash, Spinal Stenosis, Others), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Physiotherapy Centers, Home Care Settings, Others), By Surgery Type (Spinal Fusion, Disk Replacement, Foraminotomy, Diskectomy, Laminectomy, Corpectomy, Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions. The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.

  • Published On: Feb 2024
  • Author(s): Sagar Karlekar (Research Analyst)
  • Report ID: IDA55
  • Region: Global
  • Format: PDF/EXCEL

Market Analysis:

The Neck Pain Treatment Solutions Market size is expected to reach USD 20.3 billion by 2031, from USD 13.2 billion in 2023, at a CAGR of 5.5% during the forecast period by 2024-2031. Neck pain treatment solutions include products like cervical collars, muscle relaxants, epidural injections, and surgical devices that help alleviate neck pain arising from musculoskeletal disorders, injuries, poor posture etc. The growing elderly population and lifestyle habits causing neck strain are key demand drivers.

The Neck Pain Treatment Solutions Market is segmented by product, application, end-user, surgery type, and region. By product, the market is segmented into cervical collars, traction devices, epidural steroid injections, NSAIDs, opioids, muscle relaxants, and others. Opioids account for over 25% market share owing to their high analgesic properties. However, the focus is shifting towards safer non-opioid therapeutics. Medtronic launched the Intellis platform for spinal cord stimulation to precisely target neck pain.

Epidemiological Insights:

  • Neck pain has high prevalence in developed regions like North America and Europe. About 10-15% of the adult population suffers from chronic neck pain.
  • Key factors increasing prevalence are sedentary lifestyles, obesity, workplace ergonomic issues, injuries, and arthritis in the aging population.
  • As per CDC, in 2020, around 15% of American adults suffered from neck pain. In the UK, neck pain accounts for 4.9 million GP appointments annually.
  • In Japan, the lifetime neck pain prevalence is estimated to be around 47% in men and 66% in women. Neck pain incidence is rising rapidly in APAC region.
  • Degenerative disc disease and trauma/injuries are key causes. Growing cases of disc herniation, whiplash, and spinal stenosis also driving incidence.

Market Landscape

  • There is a high unmet need for non-habit forming analgesic options with minimal side-effects. Opioid addiction and abuse remain concerns.
  • Current treatment options include OTC analgesics, prescription muscle relaxants and pain medications, physiotherapy, chiropractic care, epidural steroid injections, and surgery.
  • Emerging options include medical marijuana, wearable devices delivering electrical nerve stimulation, topical CBD/menthol gels, and stem cell therapy.
  • Targeted drug therapy focusing on inflammation, regeneration of discs, and neuropathy in development. Minimally invasive procedures like MILD are advancing.
  • Market dominated by branded prescription pain relief medications like Lyrica. Generic penetration is increasing. Medical devices segment is consolidated.

Key Insights

Description

The market size in 2023

US$ 13.2 Billion

CAGR (2024 - 2031)

5.5%

The revenue forecast in 2031

US$ 20.3 Billion

Base year for estimation

2023

Historical data

2019-2023

Forecast period

2024-2031

Quantitative units

Revenue in USD Million, and CAGR from 2021 to 2031

Market segments

  • By Product Type (Cervical Collars, Traction Devices, Epidural Steroid Injections, NSAIDs, Opioids, Muscle Relaxants, Others (Physical Therapy, Acupuncture etc.))
  • By Application (Degenerative Disc Disease, Herniated Discs, Trauma and Fractures, Osteoarthritis, Whiplash, Spinal Stenosis, Others)
  • By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Physiotherapy Centers, Home Care Settings, Others)
  • By Surgery Type (Spinal Fusion, Disk Replacement, Foraminotomy, Diskectomy, Laminectomy, Corpectomy, Others)
  • By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Market Drivers

  • Aging population
  • Poor posture habits
  • Rise in musculoskeletal disorders
  • Advances in treatment technology

Market Restraints

  • Aging population
  • Poor posture habits
  • Rise in musculoskeletal disorders
  • Advances in treatment technology

Competitive Landscape

Medtronic, Johnson & Johnson, Stryker, Zimmer Biomet, NuVasive, Globus Medical, Orthofix Medical, Integra LifeSciences, DePuy Synthes

Market Drivers:

The rising prevalence of neck pain due to changing lifestyles and injuries is a major factor driving the Neck Pain Treatment Solutions Market growth. With growing cases of disc degeneration, spinal injuries and disorders like arthritis leading to neck pain, the demand for treatment options is steadily rising.

According to various studies, neck pain accounts for the third largest cause of disability globally. Long working hours spent in incorrect postures is causing strained neck muscles and ligaments, requiring therapies like physical therapy, pain relief gels/patches and chiropractic care. The launch of cervical collars with innovative ergonomic designs providing comfort and immobilization further propels market growth.

Increasing road traffic accidents and sports injuries like whiplash are also key drivers spurring the need for surgical interventions like spinal fusion and disc replacement. Minimally invasive procedures are advancing, allowing faster recovery. Robotic navigation technologies for targeted implantation of screws/rods are gaining adoption. Better reimbursement for outpatient neck surgeries is positively impacting market growth.

The geriatric population is at high risk of degenerative diseases like spinal stenosis and osteoarthritis leading to chronic neck pain. The global rise in aging demographics and their vulnerability towards musculoskeletal disorders creates significant opportunities for neck pain treatment solutions.

Market Opportunities:

The emergence of biologics and regenerative therapies utilizing stem cells, tissue engineering and platelet rich plasma represents strong growth opportunities. These therapies aim to repair damaged tissue by stimulating regeneration of discs and nerves. Companies are increasingly investing in R&D of biologics to provide lasting pain relief.

Wearable technology is another lucrative prospect. Electronic stimulators that modulate nerve signals have been shown effective for chronic neck pain. Devices allowing programmed delivery of electrical impulses to block pain signals have been developed. Their adoption is expected to rise considerably.

Demand for non-opioid, non-addictive pain medications is increasing significantly. Cannabinoids and medical marijuana gaining legalization in multiple countries provide newer, safer analgesic options for neck pain. Development of targeted drug therapies focusing on regulating inflammation and preventing neuropathic pain also gives growth opportunities.

Telemedicine and mHealth apps for virtual physiotherapy and exercise demonstrate potential in non-invasive neck pain management. Their adoption is surging driven by smartphone penetration and healthcare digitalization trends. Such platforms allow cost-effective access to specialist care.

Market Trends:

The shift towards outpatient settings for neck surgeries is a key trend shaping the market. Technological advances have made many cervical procedures minimally invasive, enabling rapid recovery and discharge within 24 hours. This transition from inpatient to outpatient facilities will likely continue due to cost benefits.

Another noticeable trend is the use of advanced surgical imaging and navigation tools. Technology like machine-learning enhanced CT/MRI scans, 3D printing of vertebral models and real-time fluoroscopy allow precision in implant placement during complex neck procedures. This improves surgery outcomes significantly.

Rising cases of sports injuries and road accidents are compelling development of emergency cervical spine treatment solutions. Devices like immobilization collars with life-saving features including airway support are gaining importance. Furthermore, emphasis on improving workplace ergonomics will continue boosting demand.

Adoption of value-based care models by healthcare providers is leading to increased bundling of neck pain treatment services like physical therapy and pain medication with surgeries. Bundling aims to improve care coordination and health outcomes while reducing costs.

Recent Developments:

Development

Company Name

In October 2022, Bioventus launched Durolane, its single-injection joint fluid supplement for treatment of neck pain due to osteoarthritis. Durolane provides long-lasting pain relief.

Bioventus

In May 2021, PainTEQ received FDA approval for its LinQ implantable peripheral nerve stimulator that helps relieve chronic neck and shoulder pain.

PainTEQ

In April 2022, Louisville Orthopaedic Clinic initiated a clinical study using NSM's StabiLok cervical interspinous stabilization system for neck pain treatment.

Neurospine Manufacturing

In January 2023, Upneeq by RVL Pharmaceuticals received FDA approval. It is the first ophthalmic solution to treat acquired blepharoptosis or drooping eyelids that can cause neck strain.

RVL Pharmaceuticals

In December 2021, Smith+Nephew acquired Engage Surgical, expanding its portfolio of surgical solutions for cervical treatments.

Smith+Nephew

In June 2022, SeaSpine entered into an agreement to acquire 7D Surgical in a cash and stock deal worth $110 million. This strengthened SeaSpine's navigation and robotic-assistance for spine surgeries.

SeaSpine

In May 2020, Alphatec acquired EOS imaging, provider of advanced imaging and 3D modeling technology for spine surgery, in an approx. $79 million deal.

Alphatec, EOS Imaging

Market Restraints:

The lack of a universally effective cure for neck pain is a major market challenge. Treatment plans need to be individualized based on pain type and cause. Moreover, pain medications have side effects while surgery carries significant risks. These factors hamper market growth.

High costs associated with surgical interventions like spinal fusion and stringent regulations related to medical device approvals are key constraints. Inadequate or no insurance coverage for emerging therapies like biologics also restricts adoption.

Diagnostic errors by physicians related to the specific origin of neck pain leads to inappropriate treatments and medication. This can worsen pain over time. Lack of training in precise diagnostic protocols for neck pain limits market expansion.

Dearth of skilled spine surgeons and neck pain specialists globally reduces access to effective treatment, especially in developing regions. Overall lack of awareness regarding available options particularly for chronic neck pain patients affects market prospects negatively.

Regional Insights:

North America is expected to dominate the Neck Pain Treatment Solutions Market during 2023-2031, accounting for over 40% of the global market share. High awareness regarding available treatment options and favorable reimbursement policies contribute to the large share of North America.

Europe accounts for the second largest market share of over 28% in the global Neck Pain Treatment Solutions Market. Increasing adoption of minimally invasive procedures in countries like Germany and France is driving growth.

The Asia Pacific market will exhibit the highest CAGR of around 7% during the forecast period owing to improving healthcare infrastructure and rising disposable incomes in the region.

Market Segmentation:

  • By Product
    • Cervical Collars
    • Traction Devices
    • Epidural Steroid Injections
    • NSAIDs
    • Opioids
    • Muscle Relaxants
    • Others
  • By Application
  • Degenerative Disc Disease
  • Herniated Discs
  • Trauma and Fractures
  • Osteoarthritis
  • Whiplash Injuries
  • Spinal Stenosis
  • Others
  • By End User
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Physiotherapy Centers
  • Home Care Settings
  • Others
  • By Surgery
    • Spinal Fusion
    • Disk Replacement
    • Foraminotomy
    • Diskectomy
    • Laminectomy
    • Corpectomy
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • Israel
      • South Africa
      • North Africa
      • Central Africa
      • Rest of the Middle East

Top companies in the Neck Pain Treatment Solutions Market:

  • Medtronic
  • Johnson & Johnson
  • Stryker Corporation
  • Zimmer Biomet
  • NuVasive, Inc.
  • Globus Medical Inc.
  • Orthofix Medical Inc.
  • Integra LifeSciences
  • Stryker Corporation
  • DePuy Synthes

Frequently Asked Questions

The Neck Pain Treatment Solutions Market is estimated to be USD 13.2 billion in 2023.

Key growth factors are rising geriatric population, sedentary lifestyles causing posture issues, increase in spinal disorders, advances in minimally invasive procedures and product innovation.

High cost of surgical interventions, unfavorable reimbursement policies, side effects of drugs like opioids and NSAIDs, low awareness in developing regions.

Opioids for pain management dominate the Neck Pain Treatment Solutions Market with over 25% share presently.

Medtronic, Johnson & Johnson, Stryker, Zimmer Biomet, NuVasive, Globus Medical, Orthofix Medical, Integra LifeSciences, DePuy Synthes.

The global Neck Pain Treatment Solutions Market is projected to reach USD 20.3 billion by 2030, growing at a CAGR of 5.5% during 2023-2031.

Rising geriatric population, increase in spinal degenerative disorders, sedentary lifestyles, product innovation, favorable reimbursement policies, and technological advancements.